Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

In the absence of a trial, a matched analysis compared cancer control after salvage focal therapy vs radical prostatectomy (RP) for radiorecurrent prostate cancer.

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.

New data show salvage focal therapy rivals surgery in radiorecurrent prostate cancer while reducing complications. Learn more about the findings.

The average age of men who get diagnosed is 67.

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

Survival rates with two approaches were similar, but one came with more complications ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

A novel, cooled laser focal therapy (cLFT) exhibits high treatment success for localized prostate cancer (PCa), according to a study published online Jan. 28 in ...